The Sickle Cell Disease Association of America (SCDAA) and the MedicAlert Foundation are partnering on a pilot program…
Mary Chapman
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Mary Chapman
A digital portrait created by artist Nikkolas Smith for the American Red Cross seeks to heighten awareness of…
With events ranging from a candlelight vigil to a new hospital exhibit to a 5K, supporters are poised to mark…
Salveo Therapeutics and the newsmagazine African Sickle Cell News and World Report — known as Sickle Cell News — are…
The Sickle Cell Disease Association of America (SCDAA) is collaborating with several pharmaceutical companies in a new initiative aimed…
Suburban Propane Partners recently teamed up with the American Red Cross, its longtime national collaborator, to host a blood drive…
Louisiana State University’s (LSU) Reilly Center for Media & Public Affairs will kick off season six of its Racism: Dismantling…
Continuing its partnership with the Sickle Cell Disease Association of America (SCDAA), medical technology company Hemanext is working…
To underscore the importance of understanding and getting tested for the sickle cell trait (SCT), the Cayenne Wellness Center…
The sickle cell disease (SCD) treatment program at Loma Linda University Children’s Hospital in California has been recognized as…